As the Pfizer/AstraZeneca takeover drama prepares for its final act on deadline-day Monday 26 May, Stelios Kavadias, Judge Business School’s Margaret Thatcher Professor of Enterprise Studies in Innovation & Growth, takes stock.
Read the full article [cambridgenetwork.co.uk]
Comments